Tuesday, November 26, 2024

Popular diabetes and obesity drugs also protect kidneys, study shows

The biggest and most comprehensive analysis of glucagon-like peptide-1 (GLP-1) receptor agonists on kidney and cardiovascular outcomes shows they have significant benefits in people with and without diabetes.

from Top Health News -- ScienceDaily https://ift.tt/CtTlSiL
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Unraveling the power and influence of language

A choice was made to include each word in this sentence. Every message, even the most mundane, is crafted with a specific frame in mind that...